局部止痛药市场规模、份额和增长分析（按治疗层级、剂型、性别、年龄组、类型、分销渠道和地区）- 2025-2032 年行业预测

2023 年全球局部止痛药市场规模价值 112 亿美元，预计将从 2024 年的 120.2 亿美元成长到 2032 年的 211.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.3%。

关节炎盛行率上升、老年人口增加以及运动员使用率增加是推动局部止痛药市场成长的主要因素。根据全面的全球市场报告，由于关节炎、骨骼疾病、糖尿病神经病变、癌症相关不适等病例的增加，该行业正呈现强劲发展势头。局部止痛产品受到青睐，因为它们比口服药物副作用少。然而，潜在的皮肤刺激和难闻的气味等挑战可能会阻碍市场的发展。然而，线上分销管道和尚未开发的新兴市场的成长为市场扩张提供了良好的机会。这种不断变化的情况凸显了局部止痛领域面临的挑战和潜在的成长途径。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 客户和购买标准分析
• 监管分析

局部止痛药市场规模（按治疗层级和复合年增长率） (2025-2032)

• 市场概况
• 非阿片类药物
  • 非类固醇消炎剂(NSAID)
  • 甲基水杨酸
  • 辣椒素
  • Lidocaine
  • 其他非鸦片类药物
• 阿片类药物
  • Buprenornhine
  • Fentanyl

局部止痛药市场规模（按剂型和复合年增长率） (2025-2032)

• 市场概况
• 奶油
• 凝胶
• 喷
• 修补
• 其他的

局部止痛药市场规模：性别与复合年增长率（2025-2032）

• 市场概况
• 女士
• 男性

局部止痛药市场规模（依年龄层划分）及复合年增长率（2025-2032 年）

• 市场概况
• 成人（18-64岁）
• 老年人（65岁以上）

局部止痛药市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 处方止痛药
• 非处方止痛药

局部止痛药市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 药局和药局
• 零售商
• 网路商店

局部止痛药市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Johnson & Johnson（United States）
• GlaxoSmithKline plc（United Kingdom）
• Novartis AG（Switzerland）
• Pfizer Inc.（United States）
• Reckitt Benckiser Group plc（United Kingdom）
• Sun Pharmaceutical Industries Ltd.（India）
• Endo International plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Sanofi SA（France）
• Mylan NV（now part of Viatris Inc.）（United States）
• AdvaCare Pharma（United States）
• Topical Biomedics Inc.（United States）

结论和建议

Global Topical Pain Relief Market size was valued at USD 11.2 billion in 2023 and is poised to grow from USD 12.02 billion in 2024 to USD 21.12 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The rising prevalence of arthritis is a key factor driving the growth of the topical pain relief market, alongside an expanding elderly population and increased use among athletes. According to a comprehensive global market report, the industry experiences significant momentum due to rising cases of arthritis, bone disorders, diabetic neuropathy, and cancer-associated discomfort. Topical pain relief products are favored for their reduced side effects compared to oral medications. However, challenges such as potential skin irritation and unpleasant odors could hinder market progress. Nevertheless, the growth of online distribution channels and untapped markets in developing regions present promising opportunities for expansion. This evolving landscape highlights both the challenges and potential avenues for growth in the topical pain relief sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The increasing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, serves as a significant catalyst for the growth of the global topical pain relief market. As more individuals experience these persistent health issues, there is an rising demand for effective, localized pain management options. Consumers are increasingly inclined towards solutions that provide both convenience and targeted relief, which topical treatments can offer. This trend highlights the importance of developing innovative and user-friendly products that cater to the specific needs of patients, driving market expansion and creating opportunities for companies in this sector.

Restraints in the Global Topical Pain Relief Market

Although topical pain relief products are commonly utilized, a significant restraint in the global market lies in the lack of comprehensive clinical evidence supporting their efficacy and safety. This gap in research affects consumer trust and can hinder the widespread adoption of these products. The uncertainty surrounding their performance may lead potential users to seek alternative pain relief options, thereby limiting market growth. Strengthening clinical trials and providing clearer data on the effectiveness and safety profiles of topical pain relief formulations are essential strategies that need to be addressed to enhance consumer confidence and encourage greater market acceptance.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the use of natural and herbal ingredients in its products, driven by a growing consumer preference for wellness-oriented solutions. As awareness of the potential side effects associated with synthetic components rises, more individuals are seeking topical pain relief options that prioritize natural formulations. This shift is not only indicative of a broader demand for cleaner, greener health products but also reflects an emerging inclination towards holistic approaches to pain management. Consequently, manufacturers are pivoting to incorporate organic, plant-based ingredients, aligning with consumer interests in sustainability and superior health benefits.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2025-2032)

• Market Overview
• Non-opioids
  • Nonsteroidal anti-inflammatory drug (NSAIDS)
  • Methyl salicylates
  • Capsaicin
  • Lidocaine
  • Other non-opioids
• Opioids
  • Buprenorphine
  • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Cream
• Gel
• Spray
• Patch
• Others

Global Topical Pain Relief Market Size by Gender & CAGR (2025-2032)

• Market Overview
• Women
• Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults (18-64 Years)
• Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2025-2032)

• Market Overview
• Prescription Pain Relief
• Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Global Topical Pain Relief Market Size & CAGR (2025-2032)

• North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • US
  • Canada
• Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AdvaCare Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topical Biomedics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations